UBS Oconnor LLC

SEC CIK: 0001132716
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CCCC holding history

C4 Therapeutics, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CCCC overview All 13F holders of CCCC Full Q4 2025 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2024

Holdings of CCCC by UBS Oconnor LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−39,868−100.0%	Sold out	Holders
Q1 2025	39,868	$63.8K	<0.1%	−97,492−71.0%	Reduced	Holders
Q4 2024	137,360	$494.5K	<0.1%	+114,360+497.2%	Added	Holders
Q3 2024	23,000	$131.1K	<0.1%	+23,000	New	Holders